CD4+ T cell depletion before NeoAg peptide vaccination resulted in partial tumor control, suggesting that helpless CD8+ T cells primed in the absence of CD4+ T cells are not fully effective, whereas depletion of CD8+ T cells just prior to therapy led to rapid tumor growth, showing that CD8+ T cells are required as effectors against SCC VII. Here, CD8A is linked to neoplasm.